These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1289371)

  • 1. Possible risk for cardiac arrhythmia related to intravenous erythromycin.
    Haefeli WE; Schoenenberger RA; Weiss P; Ritz R
    Intensive Care Med; 1992; 18(8):469-73. PubMed ID: 1289371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
    Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
    Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.
    Berger FA; van Weteringen W; van der Sijs H; Hunfeld NGM; Bunge JJH; de Groot NMS; van den Bemt PMLA; van Gelder T
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00865. PubMed ID: 34697899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients.
    Eisenhauer MD; Eliasson AH; Taylor AJ; Coyne PE; Wortham DC
    Chest; 1994 Feb; 105(2):389-95. PubMed ID: 8306734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients.
    Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG
    Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac actions of erythromycin: influence of female sex.
    Drici MD; Knollmann BC; Wang WX; Woosley RL
    JAMA; 1998 Nov; 280(20):1774-6. PubMed ID: 9842954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of erythromycin on the electrocardiogram.
    Mishra A; Friedman HS; Sinha AK
    Chest; 1999 Apr; 115(4):983-6. PubMed ID: 10208196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization.
    Hanrahan JP; Choo PW; Carlson W; Greineder D; Faich GA; Platt R
    Ann Epidemiol; 1995 May; 5(3):201-9. PubMed ID: 7606309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of ventricular arrhythmia relative to the QT interval in spontaneous intracranial hemorrhages].
    Sen S; Stober T; Burger L; Anstätt T; Rettig G; Schieffer H
    Dtsch Med Wochenschr; 1984 May; 109(21):817-20. PubMed ID: 6723536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    de Koning J; van der Hoeven H; Hamer B; Thompson J
    Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextrophropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels.
    Keller GA; Villa Etchegoyen C; Fernandez N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    J Opioid Manag; 2018; 14(5):335-344. PubMed ID: 30387857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrected QT-interval prolongation and variability in intensive care patients.
    Hoogstraaten E; Rijkenberg S; van der Voort PH
    J Crit Care; 2014 Oct; 29(5):835-9. PubMed ID: 24986247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
    Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
    Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
    Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
    Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QTc prolongation during erythromycin used as prokinetic agent in ICU patients.
    Fiets RB; Bos JM; Donders A; Bruns M; Lamfers E; Schouten JA; Kramers C
    Eur J Hosp Pharm; 2018 May; 25(3):118-122. PubMed ID: 31157004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.